证券代码：600731 证券简称：湖南海利 公告编号：2023-035 湖南海利化工股份有限公司 2023 年半年度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上海证券交易所上市公司自律监管指引第 3 号行业信息 披露：第十三号——化工》的要求，湖南海利化工股份有限公司（以下简称"公司"） 现将 2023 年半年度主要经营数据公告如下： 一、主要产品的产量、销量及收入实现情况 | 主要产品 | 2023 年 1-6 | 月平均 | 2022 年 1-6 月平均 | 同比增减（%） | | --- | --- | --- | --- | --- | | | 售价（万元/吨） | | 售价（万元/吨） | | | 氨基甲酸酯类 | 9.97 | | 10.51 | -5.21 | | 杂环类 | 11.55 | | 12.87 | -10.27 | | 有机磷类 | 18.93 | | 20.05 | -5.58 | | 剂型类 | 3.46 | | 5.60 | -38.30 | | 锂 ...

证券代码：600731 证券简称：湖南海利 公告编号： 2023－032 湖南海利化工股份有限公司 第十届八次董事会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 《公司2023年半年度报告》具体内容同日刊登在《中国证券报》、《上海证券 报》、《证券时报》、《证券日报》及上海证券交易所网站（http://www.sse.com.cn）。 二、审议通过了《公司2023年半年度募集资金存放与实际使用情况的专项报 告》 表决情况：同意9票；弃权0票；反对0票。 具体内容详见同日披露的《湖南海利化工股份有限公司关于2023年半年度募 集资金存放与实际使用情况的专项报告》（公告编号：2023－034）。 特此公告。 湖南海利化工股份有限公司董事会 2023年8月29日 湖南海利化工股份有限公司第十届八次董事会会议于2023年8月15日以书面、 传真和电子邮件的方式发出会议通知，于2023年8月25日上午在长沙市公司本部 会议室采用现场和通讯表决方式召开，会议应到董事9人，实到董事9人。会议由 刘卫东先生 ...

湖南海利化工股份有限公司第十届五次监事会会议于 2023 年 8 月 15 日以 书面、传真和电子邮件的方式发出会议通知，于 2023 年 8 月 25 日上午在长沙市 公司本部采用现场表决方式召开。会议应到监事 3 人，实到监事 3 人，会议由监 事会主席李一辉先生主持。会议的召集、召开和表决程序符合《公司法》和《公 司章程》的规定。 二、监事会会议审议情况 与会监事经认真讨论并以记名投票方式表决，审议通过以下议案： 证券代码：600731 证券简称：湖南海利 公告编号： 2023－033 湖南海利化工股份有限公司 第十届五次监事会决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、 监事会会议召开情况 一、审议通过了《公司 2023 年半年度报告》（全文和摘要） 表决情况：同意 3 票；弃权 0 票；反对 0 票。 《公司 2023 年半年度报告》具体内容同日刊登在《中国证券报》、《上海 证 券 报 》 、 《 证 券 时 报 》 、 《 证 券 日 报 》 及 上 海 证 券 交 易 所 网 站 （http:/ ...

证券代码：600731 证券简称：湖南海利 公告编号：2023-031 湖南海利化工股份有限公司 非公开发行限售股票上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： （一）非公开发行核准情况 2022 年 11 月 10 日，公司收到中国证券监督管理委员会《关于核准湖南海利 化工股份有限公司非公开发行股票的批复》（证监许可〔2022〕2671 号），核准公 司非公开发行不超过 138,536,852 股新股，核准日期为 2022 年 11 月 4 日，有效 期 12 个月。（详情请见公司于 2022 年 11 月 11 日披露的《湖南海利化工股份有限 公司关于非公开发行 A 股股票申请获得中国证监会核准批复的公告》，编号： 2022-061）。 （二）股份登记时间 公司本次发行新增股份的登记托管手续于 2023 年 2 月 16 日在中国证券登记 结算有限责任公司上海分公司办理完成。具体情况详见公司于 2023 年 2 月 18 日 在上海证券交易所网站（www.sse.com.cn）披露的《湖 ...

招商证券股份有限公司 关于湖南海利化工股份有限公司 非公开发行股票限售股解禁上市流通的核查意见 招商证券股份有限公司（以下简称"招商证券"、"保荐机构"）作为湖南海 利化工股份有限公司（以下简称"湖南海利"、"公司"）2022年度非公开发行股票 的保荐机构，根据《证券发行上市保荐业务管理办法》《上海证券交易所股票上 市规则》和《上海证券交易所上市公司自律监管指引第11号——持续督导》等相关 法律法规的要求，对湖南海利非公开发行股票限售股解禁上市流通事项进行了 审慎核查，具体核查情况及核查意见如下： 一、本次限售股上市类型 湖南海利本次上市流通的限售股类型为非公开发行限售股。 二、本次解禁限售股的基本情况 （一）非公开发行核准情况 2022年11月10日，公司收到中国证券监督管理委员会《关于核准湖南海利 化工股份有限公司非公开发行股票的批复》（证监许可〔2022〕2671号），核 准公司非公开发行不超过138,536,852股新股，核准日期为2022年11月4日，有效 期12个月。 （二）股份登记及限售安排 公司本次发行新增股份的登记托管手续于2023年2月16日在中国证券登记结 算有限责任公司上海分公司办理完 ...

证券代码：600731 证券简称：湖南海利 公告编号：2023-026 湖南海利化工股份有限公司 关于召开 2022 年度业绩暨现金分红说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 投资者可于 2023 年 05 月 05 日(星期五) 至 05 月 11 日(星期四)16:00 前登 录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 sh600731@sina.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行 回答。 湖南海利化工股份有限公司（以下简称"公司"）已于 2023 年 4 月 25 日发 布公司 2022 年度报告，为便于广大投资者更全面深入地了解公司 2022 年度经营 成果、财务状况，公司计划于 2023 年 05 月 12 日下午 15:00-16:00 举行 2022 年度业绩暨现金分红说明会，就投资者关心的问题进行交流。 一、 说明会类型 本次投资者说明会以网络互动形式召开，公司将针对 2022 年度的经营成果 及财务指标的具体情况与投资者进行互动交流和沟通， ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥590,720,878.11, a decrease of 2.78% compared to the same period last year[5]. - Net profit attributable to shareholders was ¥85,277,322.24, representing a year-on-year increase of 29.25%[6]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥82,860,371.71, up 34.74% year-on-year[6]. - Basic and diluted earnings per share were both ¥0.1620, reflecting a 13.38% increase compared to the previous year[6]. - Net profit for Q1 2023 increased by 27.00% to ¥84,444,969.15 compared to ¥66,497,475.56 in Q1 2022[20]. - The company reported a total comprehensive income of ¥84,444,969.15 for Q1 2023, compared to ¥66,497,475.56 in Q1 2022, indicating a year-over-year increase of 27.00%[21]. Cash Flow - The net cash flow from operating activities was ¥58,592,906.66, a significant improvement from a negative cash flow of ¥11,378,087.82 in the same period last year[6]. - Cash flow from operating activities generated a net amount of ¥58,592,906.66 in Q1 2023, a turnaround from a net outflow of ¥15,369,089.14 in Q1 2022[24]. - Cash inflow from financing activities in Q1 2023 was ¥729,806,907.29, significantly higher than ¥339,276,492.15 in Q1 2022[24]. - The net increase in cash and cash equivalents for Q1 2023 was $598.05 million, compared to $86.94 million in Q1 2022, reflecting a substantial rise of approximately 588%[25]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥4,524,125,841.17, an increase of 15.25% from the end of the previous year[6]. - The company's current assets totaled RMB 2,692,850,567.50, up from RMB 2,145,278,210.14, indicating an increase of about 25.6% year-over-year[17]. - Cash and cash equivalents reached RMB 1,407,241,970.58, compared to RMB 769,342,388.41 at the end of 2022, reflecting an increase of approximately 82.8%[16]. - The total liabilities decreased to RMB 1,558,366,857.68 from RMB 1,732,031,231.59, showing a reduction of about 10.0%[18]. - The company’s total liabilities and equity increased to ¥4,524,125,841.17 in Q1 2023 from ¥3,925,429,646.80 in Q1 2022[19]. Shareholder Information - Equity attributable to shareholders was ¥2,818,939,806.73, marking a 37.79% increase year-on-year[6]. - The total number of ordinary shareholders at the end of the reporting period was 25,539[12]. - The company's equity attributable to shareholders rose to RMB 2,818,939,806.73, up from RMB 2,045,866,835.50, marking an increase of approximately 37.8%[18]. Research and Development - Research and development expenses rose significantly by 71.95% to ¥30,825,402.00 in Q1 2023 from ¥17,907,713.77 in Q1 2022[19]. Non-Recurring Gains - The company reported non-recurring gains of ¥2,416,950.53 for the current period, with government subsidies contributing significantly to this figure[10].

Financial Performance - In 2022, the company achieved a net profit attributable to shareholders of RMB 352,269,305.76, with an undistributed profit at the end of the year amounting to RMB 855,970,798.26[5]. - The company's operating revenue for 2022 reached ¥3,130,113,836, representing a 13.89% increase compared to ¥2,748,472,985.8 in 2021[24]. - Net profit attributable to shareholders for 2022 was ¥352,269,305.76, a 32.10% increase from ¥266,678,700.06 in 2021[24]. - Basic earnings per share for 2022 were ¥0.7628, up 32.09% from ¥0.5775 in 2021[27]. - The total assets of the company increased by 18.79% to ¥3,925,429,646 in 2022 from ¥3,304,559,232.6 in 2021[26]. - The weighted average return on equity for 2022 was 18.65%, an increase of 2.44 percentage points from 16.21% in 2021[27]. - The company's net assets attributable to shareholders increased by 19.03% to ¥2,045,866,835 at the end of 2022 from ¥1,718,721,922.5 at the end of 2021[24]. - The company achieved an operating revenue of 3.13 billion yuan and a net profit attributable to the parent company of 352 million yuan in 2022[37]. - The company reported a net cash flow from operating activities of CNY 249,085,632.49, a 113.50% increase from the previous year, highlighting improved cash generation[55]. Investment and Capital Management - The company decided not to distribute profits or increase capital reserves for the year 2022, prioritizing funding for ongoing projects and research and development[5]. - The company is currently in a phase requiring significant capital investment due to the construction of key projects such as the Ningxia production base and the new base in Guixi[5]. - The company plans to raise up to 700 million yuan through a non-public stock issuance to support the construction of production bases[42]. - The company has not proposed any changes to its share capital structure for the year 2022[5]. - The company’s retained earnings will be used to support project construction and R&D investments, ensuring stable operations and healthy development[183]. Research and Development - The company’s research and development investment reached approximately 146 million yuan, with an R&D intensity of 4.6%, representing a 39.67% increase from the previous year[41]. - The company has applied for 19 invention patents during the reporting period, with a total of 23 authorized invention patents[41]. - The total R&D expenditure amounted to ¥145,941,302.08, representing 4.66% of total revenue[65]. - The company has developed over 100 new high-efficiency, low-risk pesticide compounds, with two insecticides and one fungicide being part of the national "13th Five-Year Plan" key research projects[84]. - The company is focusing on the development of new technologies and products, particularly in the agricultural sector, to enhance competitiveness and meet environmental standards[104]. Market Performance and Sales - Revenue from the agricultural pesticide segment reached ¥2,040,053,521.76, with a year-over-year increase of 11.81%[57]. - Lithium battery segment revenue was ¥500,531,238.73, showing a significant decrease of 77.56% year-over-year[57]. - Revenue from the overseas market was ¥1,425,148,480.06, reflecting a year-over-year increase of 51.19%[59]. - The company is actively expanding overseas markets for its agricultural products, achieving record sales in the agricultural chemical sector[39]. - The company’s sales revenue from Hailey Lithium Battery approached 500 million yuan during the reporting period[39]. Risk Management - The company faces various risks including policy, market, operational, and financial risks, which are discussed in detail in the management analysis section[9]. - The company has established a risk management framework to address credit, liquidity, and market risks associated with financial instruments[124]. - The company faces policy risks due to increasing regulatory requirements in the agricultural chemical industry, which may impact production capabilities and product compliance[113]. - The company has implemented comprehensive environmental protection measures, but faces risks of penalties if unable to meet stricter future regulations[115]. - Fluctuations in raw material prices directly affect production costs and profit margins, posing a risk to operational stability[120]. Corporate Governance - The company has received a standard unqualified audit report from Da Hua Accounting Firm[4]. - The board of directors held 11 meetings during the year, ensuring compliance with legal and regulatory requirements[135]. - The supervisory board conducted 8 meetings in 2022, maintaining compliance with relevant laws and regulations[136]. - The company has implemented performance evaluation standards and incentive mechanisms for directors, supervisors, and senior management[137]. - The company is committed to transparency in its financial reporting and governance practices, ensuring compliance with relevant regulations[140]. Employee Management - The company reported a total of 1,979 employees, with 1,875 in major subsidiaries and 104 in the parent company[175]. - The employee composition includes 934 production personnel, 112 sales personnel, 352 technical personnel, 62 financial personnel, and 291 administrative personnel[177]. - The company has implemented a multi-level compensation incentive policy, linking employee salaries closely to company performance and individual achievements[178]. - In 2022, the company organized various training programs, including safety training and modern enterprise management training, to enhance employee skills[179]. - The company plans to conduct more comprehensive talent development programs in 2023 to improve human resource capabilities[179]. Future Outlook - The company plans to strengthen its core businesses and research institutions while focusing on green industrial development and efficient project construction[106]. - The company aims to enhance competitiveness through a strategy focused on "industrial scale, product diversification, green production, international operations, precise services, and scientific management" to achieve high-quality development[105]. - The company is exploring market expansion opportunities, particularly in Southeast Asia, as production capacities shift from developed countries[104]. - The company has set ambitious performance guidance for the next fiscal year, aiming for a substantial increase in revenue[148]. - The company provided a future outlook, projecting a revenue growth of 10% for the next fiscal year[151].

2022 年第三季度报告 证券代码：600731 证券简称：湖南海利 湖南海利化工股份有限公司 2022 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人董事长刘卫东、总经理（法定代表人）尹霖、主管会计工作负责人蒋祖学及会计机构 负责人（会计主管人员）宁建文保证季度报告中财务信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | | 上年同期 | 本报告 期比上 年同期 增减变 | 年初至报 告期末 | 上年同期 | | 年初至报 告期末比 上年同期 增减变动 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | 动幅度 | | | | | | | ...

证券代码：600731 证券简称：湖南海利 公告编号：2022-055 湖南海利化工股份有限公司 关于参加湖南辖区上市公司 2022 年投资者 网上集体接待日活动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 为了进一步增强与广大投资者的互动交流，湖南海利化工股份有限公司（以 下简称"公司"） 将参加由中国证券监督管理委员会湖南监管局、湖南省上市 公司协会与深圳市全景网络有限公司联合举办的"湖南辖区上市公司投资者网上 接待日"活动，现将有关事项公告如下： 本次投资者网上集体接待日活动将通过深圳市全景网络有限公司提供的网 上平台，采取网络远程的方式举行，投资者可以登陆"全景·路演天下"网站 （http://rs.p5w.net/）参与公司本次投资者网上集体接待日活动，活动时间为 2022 年 9 月 29 日（星期四）下午 15:30－16:55，公司相关人员将与投资者进行 在线沟通与交流。欢迎广大投资者积极参加！ 特此公告。 湖南海利化工股份有限公司董事会 2022 年 9 月 24 日 ...